OK - I am struggling to see the value here.
The Cronos Australia prospectus lists an "asset-light" business as being the strength of this organisation.
In reality, there is no business here - it is a farce.
They plan to import Mile High Labs (generic CBD oil) and sell it to Australian patients under the Special Access Scheme.
REALITY CHECK
CAU have never brought a single cannabis product in to Australia
CAU have never made single dollar (Pre-revenue company)
CAU have a cultivation and manufacturing license for a now defunct facility in Daylesford which they are not intending on using
CAU have no credible cannabis-industry executives
CAU have zero patents lodged with IP-Australia
CAU have zero land ownership, zero facilities and zero assets (this is not asset-light but asset-deplete)
It is a farce and an abomination that this company raised $20M and a post-money val of $64M
This will undoubtedly deflate to an EV of $0 so a market cap of $20M which is the amount of cash they raised from gullible, (un)sophisticated investors.
CAU is not only late to the party, they have attended the wrong party.....
- Forums
- ASX - By Stock
- VIT
- CAU is massively overvalued
CAU is massively overvalued
Featured News
Add VIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.4¢ |
Change
-0.001(1.05%) |
Mkt cap ! $54.13M |
Open | High | Low | Value | Volume |
9.7¢ | 9.8¢ | 9.4¢ | $31.52K | 330.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5268 | 9.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.5¢ | 281 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.092 |
1 | 1302 | 0.091 |
3 | 26750 | 0.090 |
2 | 13376 | 0.085 |
1 | 50000 | 0.083 |
Price($) | Vol. | No. |
---|---|---|
0.095 | 281 | 1 |
0.098 | 114735 | 1 |
0.099 | 686666 | 2 |
0.100 | 57417 | 4 |
0.105 | 50000 | 1 |
Last trade - 15.44pm 15/11/2024 (20 minute delay) ? |
Featured News
VIT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online